The second part of a five-part webinar series examining value assessment in the COVID-19 era hosted by ISPOR and the Innovation and Value Initiative (IVI) will explore whether the methods on which health economists have relied are up to task or in need of improvement for the pandemic era.
Moderated by Lou Garrison, PhD (University of Washington), panelists Charles Phelps, PhD (University of Rochester), Anirban Basu, PhD (University of Washington), Susan Griffin, PhD (University of York), and Dan Ollendorf, PhD (Tufts Medical Center) will discuss what changes in value assessment methods may be needed to assess value among rapidly developing interventions, including vaccines, treatments, tests, and non-medical care.
“Our webinar series looks at value assessment through today’s pandemic lens to explore how it can be improved to meet the moment,” says Jennifer Bright, executive director, IVI. “This is an incredibly important and relevant discussion for all healthcare decision makers.”
The webinar will be from 1:00 PM – 2:15 PM EDT on Thursday, August 27th. Register for the webinar by clicking here: www.ispor.org/webinars-covid-ivi. Space is limited, so register today!
About the Innovation and Value Initiative
The Innovation and Value Initiative is a 501(c)(3) non-profit committed to advancing the science, practice, and use of value assessment in healthcare to make it more meaningful to those who receive, provide, and pay for care. To learn more, visit www.thevalueinitiative.org.